Pekin Hardy Strauss Inc. Buys New Holdings in Electromed, Inc. (NYSE:ELMD)

Pekin Hardy Strauss Inc. bought a new stake in Electromed, Inc. (NYSE:ELMDFree Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 34,750 shares of the company’s stock, valued at approximately $522,000. Pekin Hardy Strauss Inc. owned approximately 0.40% of Electromed as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in ELMD. Hunter Associates Investment Management LLC raised its holdings in Electromed by 7.1% in the first quarter. Hunter Associates Investment Management LLC now owns 86,200 shares of the company’s stock valued at $1,391,000 after acquiring an additional 5,700 shares in the last quarter. Vanguard Group Inc. raised its holdings in Electromed by 1.6% during the first quarter. Vanguard Group Inc. now owns 367,114 shares of the company’s stock worth $5,929,000 after purchasing an additional 5,886 shares in the last quarter. Gamco Investors INC. ET AL raised its holdings in Electromed by 32.6% during the first quarter. Gamco Investors INC. ET AL now owns 111,356 shares of the company’s stock worth $1,798,000 after purchasing an additional 27,356 shares in the last quarter. Gabelli Funds LLC raised its holdings in Electromed by 76.1% during the first quarter. Gabelli Funds LLC now owns 35,867 shares of the company’s stock worth $579,000 after purchasing an additional 15,500 shares in the last quarter. Finally, Aristides Capital LLC raised its holdings in Electromed by 22.1% during the first quarter. Aristides Capital LLC now owns 24,917 shares of the company’s stock worth $402,000 after purchasing an additional 4,517 shares in the last quarter. Institutional investors and hedge funds own 40.82% of the company’s stock.

Electromed Trading Up 7.7 %

ELMD stock opened at $19.83 on Wednesday. Electromed, Inc. has a twelve month low of $9.53 and a twelve month high of $20.18. The company’s 50 day moving average is $15.82 and its two-hundred day moving average is $15.77. The stock has a market cap of $171.65 million, a P/E ratio of 39.66 and a beta of 0.27.

Electromed (NYSE:ELMDGet Free Report) last released its quarterly earnings data on Tuesday, August 27th. The company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.06. Electromed had a net margin of 9.41% and a return on equity of 12.44%. The company had revenue of $14.83 million for the quarter.

About Electromed

(Free Report)

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.

See Also

Institutional Ownership by Quarter for Electromed (NYSE:ELMD)

Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.